Collectively, Exo-BSA@dBET6 can exert anti-tumor effects by inhibiting BRD4 protein expression, and modification of dBET6 with exosomes and albumin nanoparticles markedly enhanced its anti-tumor efficacy in vitro. Here, BRD4 is linked to neoplasm.